{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T15:38:52Z","timestamp":1791041932808,"version":"4.1.0"},"reference-count":13,"publisher":"American Academy of Pediatrics (AAP)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,10,1]]},"abstract":"<jats:p>A 15-year-old-boy with Noonan syndrome and status post orthoptic heart transplant developed mixed mitral valve disease and underwent mechanical mitral valve replacement 6 months before presentation with acute respiratory distress. He developed massive pulmonary hemorrhage that required veno-venous extracorporeal membrane oxygenation (ECMO) support. He had a prolonged anticoagulation free ECMO course of 4 weeks, with ongoing recurrent pulmonary hemorrhage and underwent several rounds of coil embolization of aortopulmonary collaterals. ECMO course was complicated by significant nasopharyngeal bleeding that required embolization of the sphenopalatine artery. Shortly after decannulation, he developed massive gastrointestinal and peritoneal hemorrhage that was treated by embolization of the left gastric artery and a branch of the internal iliac artery. His bleeding was attributed to neo-angiogenesis. Initial treatment with propranolol was unsuccessful. Subsequent treatment with interferon \u03b1 2b demonstrated efficacy, but severe neutropenia required cessation of therapy. Because functional alterations of the rat sarcoma virus-mitogen activated protein kinase signaling pathway and protein tyrosine phosphatase nonreceptor type (PTPN11) mutations in Noonan syndrome are known to be associated with neo-angiogenesis, we used the mitogen-activated protein kinase inhibitor selumetinib as a gene-targeted therapy with the hope of controlling bleeding and inhibiting neo-angiogenesis. After initiation of selumetinib, bleeding stopped and allowed the patient to be discharged from the hospital on dipyridamole as antiplatelet prophylaxis for his mechanical mitral valve. He had no further bleeding episodes through 1 year after hospital discharge.<\/jats:p>","DOI":"10.1542\/peds.2022-056336","type":"journal-article","created":{"date-parts":[[2022,9,9]],"date-time":"2022-09-09T08:39:21Z","timestamp":1662712761000},"source":"Crossref","is-referenced-by-count":8,"title":["Selumetinib for Refractory Pulmonary and Gastrointestinal Bleeding in Noonan Syndrome"],"prefix":"10.1542","volume":"150","author":[{"given":"Abhishek","family":"Chakraborty","sequence":"first","affiliation":[{"name":"aDivision of Pediatric Cardiology, University of Tennessee, Le Bonheur Children\u2019s Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Beasley","sequence":"additional","affiliation":[{"name":"aDivision of Pediatric Cardiology, University of Tennessee, Le Bonheur Children\u2019s Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Martinez","sequence":"additional","affiliation":[{"name":"aDivision of Pediatric Cardiology, University of Tennessee, Le Bonheur Children\u2019s Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohith","family":"Jesudas","sequence":"additional","affiliation":[{"name":"bDepartment of Clinical Hematology, St. Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pilar","family":"Anton-Martin","sequence":"additional","affiliation":[{"name":"aDivision of Pediatric Cardiology, University of Tennessee, Le Bonheur Children\u2019s Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Christakopoulos","sequence":"additional","affiliation":[{"name":"bDepartment of Clinical Hematology, St. Jude Children\u2019s Research Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Kramer","sequence":"additional","affiliation":[{"name":"aDivision of Pediatric Cardiology, University of Tennessee, Le Bonheur Children\u2019s Hospital, Memphis, Tennessee"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"417","published-online":{"date-parts":[[2022,9,9]]},"reference":[{"issue":"2","key":"2023110816465619300_B1","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/ajmg.1320310208","article-title":"Bleeding diathesis in Noonan syndrome: a common association","volume":"31","author":"Witt","year":"1988","journal-title":"Am J Med Genet"},{"issue":"5","key":"2023110816465619300_B2","doi-asserted-by":"crossref","first-page":"e1299","DOI":"10.1542\/peds.2013-3251","article-title":"Hemostatic abnormalities in Noonan syndrome","volume":"133","author":"Artoni","year":"2014","journal-title":"Pediatrics"},{"issue":"2","key":"2023110816465619300_B3","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1074\/jbc.M804129200","article-title":"Noonan syndrome\/leukemia-associated gain-of-function mutations in SHP-2 phosphatase (PTPN11) enhance cell migration and angiogenesis","volume":"284","author":"Wang","year":"2009","journal-title":"J Biol Chem"},{"key":"2023110816465619300_B4","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2147\/JBM.S164474","article-title":"Evaluation of bleeding disorders in patients with Noonan syndrome: a systematic review","volume":"9","author":"Nugent","year":"2018","journal-title":"J Blood Med"},{"issue":"1","key":"2023110816465619300_B5","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1007\/s10038-004-0212-x","article-title":"Genetic heterogeneity in LEOPARD syndrome: two families with no mutations in PTPN11","volume":"50","author":"Kalidas","year":"2005","journal-title":"J Hum Genet"},{"issue":"2","key":"2023110816465619300_B6","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/pbc.23358","article-title":"Bleeding disorders in Noonan syndrome","volume":"58","author":"Briggs","year":"2012","journal-title":"Pediatr Blood Cancer"},{"issue":"10","key":"2023110816465619300_B7","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1111\/j.1651-2227.1996.tb18225.x","article-title":"Noonan syndrome: coagulation and clinical aspects","volume":"85","author":"Massarano","year":"1996","journal-title":"Acta Paediatr"},{"issue":"8","key":"2023110816465619300_B8","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1002\/humu.20748","article-title":"The RAS\/MAPK syndromes: novel roles of the RAS pathway in human genetic disorders","volume":"29","author":"Aoki","year":"2008","journal-title":"Hum Mutat"},{"issue":"6","key":"2023110816465619300_B9","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jpeds.2011.05.024","article-title":"Spectrum of mutations in Noonan syndrome and their correlation with phenotypes","volume":"159","author":"Lee","year":"2011","journal-title":"J Pediatr"},{"issue":"3","key":"2023110816465619300_B10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1002\/(SICI)1096-8628(19990129)82:3<212::AID-AJMG3>3.0.CO;2-4","article-title":"Noonan syndrome and cavernous hemangioma of the brain","volume":"82","author":"Tanaka","year":"1999","journal-title":"Am J Med Genet"},{"issue":"15","key":"2023110816465619300_B11","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1912735","article-title":"Selumetinib in children with inoperable plexiform neurofibromas","volume":"382","author":"Gross","year":"2020","journal-title":"N Engl J Med"},{"issue":"6","key":"2023110816465619300_B12","doi-asserted-by":"crossref","first-page":"e20200167","DOI":"10.1542\/peds.2020-0167","article-title":"Severe lymphatic disorder resolved with MEK inhibition in a patient with Noonan syndrome and SOS1 mutation","volume":"146","author":"Dori","year":"2020","journal-title":"Pediatrics"},{"key":"2023110816465619300_B13","unstructured":"US Food and Drug Administration\n          . Highlights of prescribing information. Available at: https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2020\/213756s000lbl.pdf. Accessed February 2, 2022"}],"container-title":["Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2022-056336\/1562076\/peds_2022056336.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/publications.aap.org\/pediatrics\/article-pdf\/doi\/10.1542\/peds.2022-056336\/1562076\/peds_2022056336.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T16:47:45Z","timestamp":1699462065000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.aap.org\/pediatrics\/article\/150\/4\/e2022056336\/189468\/Selumetinib-for-Refractory-Pulmonary-and"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,9,9]]},"references-count":13,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2022,9,9]]},"published-print":{"date-parts":[[2022,10,1]]}},"URL":"https:\/\/doi.org\/10.1542\/peds.2022-056336","relation":{},"ISSN":["0031-4005","1098-4275"],"issn-type":[{"value":"0031-4005","type":"print"},{"value":"1098-4275","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,9,9]]},"article-number":"e2022056336"}}